Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease

Table 2

Demographic and clinical characteristics of patients with Kawasaki disease who had a response to IVIG or were IVIG resistant.

Variable	IVIG response (𝑛=58)	IVIG resistance (𝑛=5)	P value
Age (months)	21.66±19.12	12.28±6.72	0.491
Sex (M : F)	37 : 21	2 : 3	0.866
Days of fever before admission	5.02±1.82	4.89±2.32	0.453
CAL	7/58	5/5	<0.001*
Hemoglobin	10.54±1.38	11.21±2.11	0.432
WBC	12262.9±3163.4	13100.9±3528.3	0.520
Segment (%)	63.22±10.86	64.21±11.10	0.273
Lymphocyte (%)	23.04±8.23	22.31±9.15	0.172
Monocyte (%)	5.93±3.12	6.14±3.82	0.383
Eosinophil (%)	3.32±3.15	2.62±2.76	0.482
Basophil (%)	0.22±0.42	0.32±1.21	0.712
AST (U/L)	80.56±51.38	95.32±69.22	0.354
Platelet (×10^4/mm^3)	35.36±11.41	35.84±14.71	0.235
CRP(mg/L)	95.12±53.29	137.34±136.38	0.389
Kappa (mg/L)	4.74±5.19	5.21±1.49	0.844
Lambda (mg/L)	12.96±12.01	15.02±8.99	0.714
A1AT (mg/dL)	186.51±29.34	198.61±18.49	0.375

Data are presented as mean ± standard deviation for quantitative variables. CAL: coronary artery lesion; WBC: white blood cells; AST: aspartate aminotransferase; ALT: alanine aminotransferase; CRP: C-reactive protein. A1AT: alpha-1-antitrypsin. *P < 0.05 was considered statistically significant difference.